Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New imaging device aims to improve wound measurement

NCT ID NCT06682923

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special camera called the MolecuLight DX that uses fluorescence to measure the size of skin wounds. 34 adults with various types of wounds (like diabetic foot ulcers) took part. The goal was to see if the device measures wound area more accurately than a standard ruler. The study is now complete.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MolecuLight DX Imaging Device
What this could lead to
If successful, this device could help doctors measure wounds more accurately, leading to better wound care.
What could go wrong
This is a small, completed study with only 34 people. It only tested measurement accuracy, not whether it improves healing or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

34 people

The number who actually took part.

Started

Oct 2024

Finished

Feb 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults 22 years and older with surface wounds

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willing to consent * Willing to comply with all study procedures and availability for the duration of the study * Male or female, aged over 22 years old * Presented with diabetic foot ulcers, venous, arterial and pressure ulcers * Wound size is greater than 0.5 cm2 * The wound has well-defined wound borders Exclusion Criteria: * Circumferential wound * Wound without clearly defined wound borders * Wound located in a difficult to reach/measure location * Any contra-indication to routine wound care and/or monitoring * Wounds with a length greater than 18.5cm or a width greater than 13.5cm. * Tunneled or undermined wounds

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pressure ulcer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Judy Dan Centre for Hyperbaric Medicine & Advance Wound Care

    North York, Ontario, M2R 1N5, Canada

  • The Mayer Institute

    Hamilton, Ontario, L8R 2R3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.